 |
|
Permethrin-Resistant Human Head Lice, Pediculus capitis, and Their Treatment
Kyong Sup Yoon, MS;
Jian-Rong Gao, PhD;
Si Hyeock Lee, PhD;
J. Marshall Clark, PhD;
Leon Brown, MS;
David Taplin, PhD
Arch Dermatol. 2003;139:994-1000.
Objective To compare the pediculicidal activity of Ovide lotion and its active ingredient, 0.5% malathion, with Nix and its active ingredient, 1% permethrin, in permethrin-resistant head lice.
Design In vitro pediculicidal product and active ingredient comparison. The presence of knockdown resistance–type mutations (T929I and L932F) was validated by DNA sequencing.
Setting University of Massachusetts-Amherst; University of Miami School of Medicine, Miami, Fla; Plantation and Homestead, Fla; and Mathis, Tex.
Other Participants Lice were collected in 3 geographical regions within the United States and in Yamburara, Ecuador, from healthy but infested individuals.
Intervention Within 3 to 6 hours of collection, lice were given a blood meal, exposed to products or active ingredients, and observed at regular intervals.
Main Outcome Measures Percent mortality of lice at regular intervals after exposure to products or active ingredients and presence of T929I and L932F mutations.
Results South Florida lice exhibited a significantly slower mortality response to permethrin compared with susceptible Ecuadorian lice. Ovide and malathion killed permethrin-resistant lice faster than Nix or permethrin. The presence of T929I and L932F in permethrin-resistant south Florida lice was confirmed by DNA sequencing. The population of Texas lice from Mathis was slightly resistant to permethrin and included 13% with resistant genotypes.
Conclusions The presence of the T929I and L932F mutations was confirmed by DNA sequencing in lice collected from children in south Florida that were resistant to the pediculicidal effects of permethrin and the leading permethrin-based head lice product, Nix. Malathion resistance was not observed in this study. The data also show that Ovide killed these same permethrin-resistant head lice approximately 10 times faster than permethrin or Nix.
From the Department of Entomology, University of Massachusetts-Amherst (Mr Yoon and Drs Gao and Clark); the Department of Agricultural Biotechnology, Seoul National University, Suwon, South Korea (Dr Lee); Martin & Cukjati, San Antonio, Tex (Mr Brown); and the Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, Fla (Dr Taplin). The authors have no relevant financial interest in this article.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLE
Drug-Resistant Lice
Dirk M. Elston
Arch Dermatol. 2003;139(8):1061-1064.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Therapy for Head Lice Based on Life Cycle, Resistance, and Safety Considerations
Lebwohl et al.
Pediatrics 2007;119:965-974.
ABSTRACT
| FULL TEXT
Bug Buster for head lice: is it effective?
Chosidow
Arch Dermatol 2006;142:1635-1637.
FULL TEXT
A Possible Method for Suffocating Head Lice
Yan and Barton
AAP Grand Rounds 2004;12:74-75.
FULL TEXT
Relationship of Treatment-Resistant Head Lice to the Safety and Efficacy of Pediculicides
Burkhart
Mayo Clin Proc. 2004;79:661-666.
ABSTRACT
Head Lice Revisited: In Vitro Standardized Tests and Differences in Malathion Formulations
Arch Dermatol 2004;140:488-489.
Scratching Your Head Over Resistant Head Lice
JWatch Pediatrics 2003;2003:10-10.
FULL TEXT
Managing a Lousy Problem: Permethrin- Resistant Head Lice
Yan
AAP Grand Rounds 2003;10:62-63.
FULL TEXT
Scratching Your Head Over Resistant Head Lice
Journal Watch Dermatology 2003;2003:1-1.
FULL TEXT
Drug-Resistant Lice
Elston
Arch Dermatol 2003;139:1061-1064.
FULL TEXT
|
